Pages that link to "Q41936910"
Jump to navigation
Jump to search
The following pages link to Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients (Q41936910):
Displaying 50 items.
- A reflection on HIV/AIDS research after 25 years (Q21245200) (← links)
- Reverse transcription of the HIV-1 pandemic (Q22242815) (← links)
- Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine (Q24644271) (← links)
- Sulfation of the human immunodeficiency virus envelope glycoprotein (Q24647955) (← links)
- Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection (Q24652969) (← links)
- A brief history of the global effort to develop a preventive HIV vaccine (Q26851165) (← links)
- HIV-1 neutralizing antibodies: understanding nature's pathways (Q27000480) (← links)
- Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates (Q27629806) (← links)
- Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site (Q27681568) (← links)
- Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum (Q28214904) (← links)
- Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function (Q28293345) (← links)
- An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitors (Q28477736) (← links)
- Virus neutralisation: new insights from kinetic neutralisation curves (Q28487427) (← links)
- Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1 (Q28646731) (← links)
- Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein (Q28646850) (← links)
- Oligomer-specific conformations of the human immunodeficiency virus (HIV-1) gp41 envelope glycoprotein ectodomain recognized by human monoclonal antibodies (Q30436401) (← links)
- Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein (Q30454762) (← links)
- Novel strategy for the selection of human recombinant Fab fragments to membrane proteins from a phage-display library (Q31039719) (← links)
- Analysis of the subunit stoichiometries in viral entry (Q31053897) (← links)
- Matrix-assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody (Q32049913) (← links)
- Estimating the stoichiometry of HIV neutralization (Q33545224) (← links)
- Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120 (Q33571605) (← links)
- Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120 (Q33632668) (← links)
- Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles (Q33660809) (← links)
- CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies (Q33743734) (← links)
- Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines (Q33780524) (← links)
- Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions (Q33789251) (← links)
- Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution (Q33804811) (← links)
- Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins (Q33806056) (← links)
- Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers (Q33836042) (← links)
- Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys (Q33839485) (← links)
- Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants (Q33850415) (← links)
- Induction of anti-HIV neutralizing antibodies by synthetic peptides (Q33880796) (← links)
- Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus (Q33929366) (← links)
- Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor (Q33929700) (← links)
- Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events (Q33936268) (← links)
- Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein (Q33937274) (← links)
- Conformational characterization of aberrant disulfide-linked HIV-1 gp120 dimers secreted from overexpressing cells. (Q34020606) (← links)
- Use of murine CXCR-4 as a second receptor by some T-cell-tropic human immunodeficiency viruses (Q34070351) (← links)
- A second post-transcriptional trans-activator gene required for HTLV-III replication (Q34162178) (← links)
- Mechanisms of infectivity and replication of HIV-1 and implications for therapy (Q34203154) (← links)
- Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein (Q34301897) (← links)
- Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants (Q34302085) (← links)
- Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins (Q34334135) (← links)
- Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells (Q34350730) (← links)
- Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus (Q34364045) (← links)
- Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine (Q34373003) (← links)
- The Active Core in a Triazole Peptide Dual‐Site Antagonist of HIV‐1 gp120 (Q34558123) (← links)
- Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120 (Q34628114) (← links)
- Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif. (Q34648342) (← links)